Formulate
Jobs
Companies
Products
Indications
Toggle theme
Toggle theme
Menu
Home
Products
ROLVEDON
ROLVEDON
Peak
eflapegrastim-xnst
Spectrum Dynamics
BLA
SUBCUTANEOUS
INJECTABLE
Approved
Sep 2022
Lifecycle
Peak
Competitive Pressure
30
/100
Overview
Competitive Landscape
10
Related Jobs
10
Mechanism of Action
Pharmacologic Class:
Leukocyte Growth Factor
Company
Spectrum Dynamics
FL - Sarasota
19 open jobs
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers